Sign in
Enrolling by invitationPhase 4

Comparing Treatments for Common Neurological Conditions Using Electronic Medical Records

Compares treatments for brain tumors, epilepsy, migraine and other neurological conditions in adults.

Key facts

Who runs it
Endeavor Health
Where
Evanston, United StatesSee the site
Trial code
Registry title
Quality Improvement and Practice Based Research in Neurology Using the EMR
Status
Enrolling by invitation
Phase
Phase 4
People taking part
3,300 people, planned
Started
May 2016
Expected to end
Dec 2027
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Listed for each disorder below, up to three drugs per disorder (too many characters to list in this field; see Intervention Description)
Record updated
24 August 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with one of 10 common brain and nerve conditions, such as epilepsy, migraine, Parkinson's disease or stroke. They can receive one of three compared treatments.

Age
18 Years to 100 Years
Sex
All sexes can join.
Disease stage
Diagnosis of brain tumors, epilepsy, migraine, mild cognitive impairment (concussion), mild traumatic brain injury, multiple sclerosis, neuropathy, Parkinson's disease, restless legs syndrome, or stroke.

Main reasons for not taking part

  • The record lists no exclusion criteria ("None").
  • People who cannot receive any of the three compared treatments (FDA-approved use or off-label use by standard of care) cannot join.

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Diagnosis of brain tumors, epilepsy, migraine, mild cognitive impairment (concussion), mild traumatic brain injury, multiple sclerosis, neuropathy, Parkinson's disease, restless legs syndrome, and stroke
  • Eligible to receive any of the three compared treatments according to FDA approval for the indication or off label use according to standard of care

Who cannot take part

  • -- None

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 100 years old?

Where in United States

  • NorthShore University HealthSystemEvanston, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

The investigators will conduct at NorthShore University HealthSystem pragmatic trials using the EMR for 10 common neurological disorders. They will demonstrate the feasibility of subgroup based adaptive assignment of treatments, electronic consenting, and outcomes data capture at the point of care using the EMR. They will identify the most effective treatments for common neurological disorders and seek replication by the NPBRN.

The 3 groups in the trial

  • Treatment A (see interventions description)Existing treatment, for comparison

    The investigators will conduct 11 pragmatic trials using the EMR: brain tumors (prevent seizures), epilepsy (prevent other seizure types), mild cognitive impairment (improve memory), migraine (prevention), migraine (abortive), mild traumatic brain injury (prevent post concussion syndrome), multiple sclerosis (attenuate relapses), neuropathy (pain management), Parkinson's (treat motor symptoms), restless legs syndrome (treat sensory symptoms), stroke (secondary prevention). For each trial they will compare up to three medications or treatments either FDA approved for the indication, or commonly employed. The pragmatic trials will be small and primarily to demonstrate the feasibility of subgroup based adaptive assignment of treatments, electronic consenting, and data capture at the point of care using the EMR. The focus is on the development of the study design and methodology and not on the treatments per se.

    Treatment: Listed for each disorder below, up to three drugs per disorder (too many characters to list in this field; see Intervention Description)

  • Treatment B (see interventions description)Existing treatment, for comparison

    The investigators will conduct 11 pragmatic trials using the EMR: brain tumors (prevent seizures), epilepsy (prevent other seizure types), mild cognitive impairment (improve memory), migraine (prevention), migraine (abortive), mild traumatic brain injury (prevent post concussion syndrome), multiple sclerosis (attenuate relapses), neuropathy (pain management), Parkinson's (treat motor symptoms), restless legs syndrome (treat sensory symptoms), stroke (secondary prevention). For each trial they will compare up to three medications or treatments either FDA approved for the indication, or commonly employed. The pragmatic trials will be small and primarily to demonstrate the feasibility of subgroup based adaptive assignment of treatments, electronic consenting, and data capture at the point of care using the EMR. The focus is on the development of the study design and methodology and not on the treatments per se.

    Treatment: Listed for each disorder below, up to three drugs per disorder (too many characters to list in this field; see Intervention Description)

  • Treatment C (see interventions description)Existing treatment, for comparison

    The investigators will conduct 11 pragmatic trials using the EMR: brain tumors (prevent seizures), epilepsy (prevent other seizure types), mild cognitive impairment (improve memory), migraine (prevention), migraine (abortive), mild traumatic brain injury (prevent post concussion syndrome), multiple sclerosis (attenuate relapses), neuropathy (pain management), Parkinson's (treat motor symptoms), restless legs syndrome (treat sensory symptoms), stroke (secondary prevention). For each trial they will compare up to three medications or treatments either FDA approved for the indication, or commonly employed. The pragmatic trials will be small and primarily to demonstrate the feasibility of subgroup based adaptive assignment of treatments, electronic consenting, and data capture at the point of care using the EMR. The focus is on the development of the study design and methodology and not on the treatments per se.

    Treatment: Listed for each disorder below, up to three drugs per disorder (too many characters to list in this field; see Intervention Description)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Quality Improvement and Practice Based Research in Neurology Using the Electronic Medical Record
Plain-language title
Comparing Treatments for Common Neurological Conditions Using Electronic Medical RecordsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT02670161, who can take part
Record updated
24 August 2025